Advertisement
Clinical Communications: Adult| Volume 58, ISSUE 6, e247-e249, June 2020

Acute Airway Inflammation Caused By Incomplete Ingestion of Extended-Release Diltiazem: A Case Report

  • William Manning
    Affiliations
    Department of Emergency Medicine, Prisma Health–Upstate, Greenville Memorial Hospital, Greenville, South Carolina
    Search for articles by this author
  • Benjamin S. Roth
    Correspondence
    Reprint Address: Benjamin S. Roth, md, Department of Emergency Medicine, Greenville Memorial Hospital, 701 Grove Road, Greenville, SC 29605
    Affiliations
    Department of Emergency Medicine, Prisma Health–Upstate, Greenville Memorial Hospital, Greenville, South Carolina

    School of Medicine Greenville, University of South Carolina, Greenville, South Carolina
    Search for articles by this author

      Abstract

      Background

      Diltiazem in its extended-release formulation is widely prescribed and is generally well-tolerated. Currently, there are no published case reports of localized inflammation related to extended-release diltiazem causing either significant pill esophagitis or airway inflammation when swallowed incompletely.

      Case Report

      We present a case of an 85-year-old female who reported difficulty swallowing roughly 18 h after incomplete ingestion of an extended-release diltiazem tablet. She had mild stridor and visible right-sided neck swelling on examination. Imaging revealed a large inflammatory mass, which was believed to be a subacute to chronic neoplastic process when reviewed both by radiology and otolaryngology. Two days after presentation, however, the patient's symptoms and the inflammatory mass had resolved entirely.

      Why Should an Emergency Physician Be Aware of This?

      Extended-release diltiazem can cause an inflammatory mass when ingested incompletely, leading to possible acute airway compromise. Any invasive airway intervention should be approached with caution, given the degree of acute inflammation. Even in patients who do not require intervention, close observation until clinical improvement is warranted in symptomatic patients with a history of recent incomplete ingestion of extended-release diltiazem.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Reference

        • Simko V.
        • Joseph D.
        • Michael S.
        Increased risk of esophageal obstruction with slow-release medications.
        J Assoc Acad Minor Phys. 1997; 8: 38-42